DDX53 and colonic neoplasm: We found that mRIP3 promoted CT26 colon cancer growth, while the promoting effect of mRIP3 was reverted by mPRMT1(Fig. 5C, D), suggesting that mPRMT1 inhibits the mRIP3-dependent colon cancer growth.